Title : Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B.

Pub. Date : 2017 Mar

PMID : 27890790






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 LAY SUMMARY: IFN-free therapy with oral direct-acting antiviral drugs (daclatasvir and asunaprevir) for HCV infection showed similar tolerability and antiviral efficacy in patients aged >=80years as in younger patients (patients aged >=70 and <80years and patients aged <70years), with an SVR rate over 90% and no severe adverse effects. daclatasvir interferon alpha 1 Homo sapiens